Publication | Open Access
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
151
Citations
27
References
2023
Year
Among patients in hemodynamically stable condition with STEMI and multivessel coronary artery disease, immediate multivessel PCI was noninferior to staged multivessel PCI with respect to the risk of death from any cause, nonfatal myocardial infarction, stroke, unplanned ischemia-driven revascularization, or hospitalization for heart failure at 1 year. (Supported by Boston Scientific; MULTISTARS AMI ClinicalTrials.gov number, NCT03135275.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1